Cardiff Oncology Inc (CRDF)

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 08, 2026

CRDF Technical Analysis & Stock Price Forecast - Intellectia AI

May 08, 2026

May 06, 2026

MSN Money - MSN

May 06, 2026

May 04, 2026

Cardiff Oncology Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView

May 04, 2026

Apr 29, 2026

CRDF Q1'26 Earnings: EPS estimate is (0.13) USD - TradingView

Apr 29, 2026

Apr 28, 2026

[Form 4] Cardiff Oncology, Inc. Insider Trading Activity - Stock Titan

Apr 28, 2026

Apr 28, 2026

Cardiff Oncology (CRDF) COO Ajay Aggarwal submits initial insider ownership - Stock Titan

Apr 28, 2026

Apr 28, 2026

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

Apr 28, 2026

Apr 28, 2026

CRDF SEC FilingsCardiff Oncology Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 28, 2026

Apr 27, 2026

Cardiff Oncology appoints Mani Mohindru as CEO - MSN

Apr 27, 2026

Apr 27, 2026

Cardiff Oncology Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

Apr 27, 2026

Apr 27, 2026

Cardiff Oncology to Host Key Opinion Leader Discussion on Onvansertib’s Promising Single-Agent Activity - GlobeNewswire

Apr 27, 2026

Apr 27, 2026

Mayo Clinic leukemia expert joins Cardiff webinar on CMML drug data - Stock Titan

Apr 27, 2026

Apr 26, 2026

Cardiff Oncology (CRDF) price target decreased by 17.38% to 8.74 - MSN

Apr 26, 2026

Apr 23, 2026

Cardiff Oncology slumps after leadership shakeup - MSN

Apr 23, 2026

Apr 23, 2026

[ARS] Cardiff Oncology, Inc. SEC Filing - Stock Titan

Apr 23, 2026

Apr 23, 2026

[DEF 14A] Cardiff Oncology, Inc. Definitive Proxy Statement - Stock Titan

Apr 23, 2026

Apr 23, 2026

CRDF Q1'26 Earnings: revenue estimate is 88.57K USD - TradingView

Apr 23, 2026

Apr 22, 2026

CRDF (Cardiff Oncology Inc.) reports narrower than expected Q4 2025 loss, shares climb 4.29% on positive investor sentiment.Buyback Report - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026

Apr 22, 2026

Cardiff Oncology to present colorectal cancer trial data at ASCO By Investing.com - Investing.com Nigeria

Apr 22, 2026

Apr 21, 2026

Cardiff Oncology to present colorectal cancer trial data at ASCO - Investing.com

Apr 21, 2026

Apr 21, 2026

Cardiff Oncology to Present Updated Data on Onvansertib in RAS-Mutated Colorectal Cancer at ASCO 2026 - Quiver Quantitative

Apr 21, 2026

Apr 21, 2026

Updated metastatic colon cancer data gets ASCO oral slot - Stock Titan

Apr 21, 2026

Apr 21, 2026

Cardiff Oncology, Inc. (NASDAQ:CRDF) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Apr 21, 2026

Apr 20, 2026

H.C. Wainwright reiterates Cardiff Oncology stock rating at buy By Investing.com - Investing.com Canada

Apr 20, 2026

Apr 18, 2026

Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting - Sahm

Apr 18, 2026

Apr 18, 2026

Cardiff Oncology presents preclinical data on cancer drug combo By Investing.com - Investing.com India

Apr 18, 2026

Apr 17, 2026

Cardiff Oncology (CRDF) Unveils Promising Preclinical Data at AA - GuruFocus

Apr 17, 2026

Apr 17, 2026

Cardiff Oncology presents preclinical data on cancer drug combo - Investing.com

Apr 17, 2026

Apr 16, 2026

Cardiff Oncology (CRDF) CFO discloses initial holding of 500 common shares - Stock Titan

Apr 16, 2026

Apr 16, 2026

Cardiff Oncology (NASDAQ: CRDF) CFO awarded 486,650 stock options - Stock Titan

Apr 16, 2026

Apr 16, 2026

Cardiff Oncology (CRDF) CSO granted 300,000 stock options expiring 2036 - Stock Titan

Apr 16, 2026

Apr 16, 2026

Cardiff Oncology (CRDF) CFO receives 486,650 options at $1.58 strike - Stock Titan

Apr 16, 2026

Apr 16, 2026

Cardiff Oncology | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Muntner Joshua Bmoomoo - Moomoo

Apr 16, 2026

Apr 11, 2026

Momentum Shift: Is Cardiff Oncology Inc likely to announce a buyback2026 Breakouts & Breakdowns & Smart Swing Trading Techniques - baoquankhu1.vn

Apr 11, 2026